FDA Clears Updated Hermia Voxel Dosimetry Software
The new release adds machine learning–based organ segmentation, faster dose calculations, and automated workflow features.
The new release adds machine learning–based organ segmentation, faster dose calculations, and automated workflow features.
The Class I recall involves devices with incorrectly assembled B/V filters.
Certain Z-800 series infusion pumps may malfunction due to unverified software, prompting a Class I recall by the FDA.
The software, powered by artificial intelligence and deep learning, assesses angiography-derived coronary physiology in patients with ischemic coronary artery disease.
Devices are being removed from use after certain sizes were found to have smaller diameters than expected, potentially limiting airflow. Eight injuries have been reported.
Admetsys announced that the FDA has designated its automated glucose control and continuous blood diagnostics system a Breakthrough Device.
The U.S. FDA has proposed banning electrical stimulation devices for self-injurious or aggressive behavior due to significant risks, marking the second attempt at prohibition, with implications including potential treatment transitions for users and a thorough review of updated evidence and expert opinions.